VAERS reports by lot

Moderna COVID-19 lot AS7170B: VAERS reports

145 VAERS reports list lot AS7170B as a Moderna COVID-19 vaccine, received between 2022-12-23 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
145
Reports
6%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4625%
Neurological2212%
Respiratory2111%
Musculoskeletal1810%
Cardiac / Cardiovascular179%
Injection-site / Local reaction179%
Gastrointestinal169%
Dermatological (non-injection-site)169%
Allergic / Anaphylactic84%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California11
Texas10
Oklahoma10
Florida9
Michigan8
Washington7
New Jersey6
Massachusetts5
Wisconsin4
Minnesota4
Ohio4
Indiana4

Reports by month received

2022-124
2023-0148
2023-0215
2023-0329
2023-0410
2023-0512
2023-0615
2023-075
2023-082
2023-091
2024-011
2024-032
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.